Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Nippon India |
| NAV | ₹792.8942 | ₹29.1863 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 10.0 years | 5.4 years |
| Expense ratio | 0.2% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +6.63% | +10.82% |
| 3 months | −1.25% | +7.43% |
| 6 months | +6.05% | +14.54% |
| YTD | +6.38% | +25.40% |
| 1 year | +6.08% | +25.57% |
| 3 years (CAGR) | +16.90% | +22.02% |
| 5 years (CAGR) | +11.65% | +16.60% |
| 10 years (CAGR) | +13.92% | — |
| Since launch | +13.14% | +14.02% |
Risk
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | 20.3% | 15.0% |
| Downside volatility | 13.4% | 9.0% |
| Sharpe | 0.51 | 1.04 |
| Sortino | 0.78 | 1.72 |
| Calmar | 0.64 | 1.33 |
| Return / risk | 0.83 | 1.47 |
| Deepest fall | −40.54% | −20.98% |
| Days to recover | 255 | 136 |
| Below its high | −4.32% | −1.75% |
Against benchmark
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | +0.37% | +0.00% |
| Beta | 1.00 | 1.00 |
| R² | 100.0% | 100.0% |
| Up capture | 100.6% | 100.0% |
| Down capture | 99.3% | 100.0% |
| Tracking error | 0.2% | 0.0% |
| Information ratio | 2.35 | — |
| Treynor | 0.09 | 0.14 |
Consistency
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +88.43% | +65.21% |
| Middle 1-year | +6.85% | +13.46% |
| Worst 1-year | −32.52% | −15.30% |
| 1-year periods with a loss | 29.0% | 25.8% |
| Middle 3-year | +16.77% | +20.51% |
| Positive months | 69.4% | 61.1% |
| Best day | +4.74% | +3.64% |
| Worst day | −9.33% | −4.03% |
| Worst 5% day | −2.11% | −1.62% |
| Positive days | 58.4% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | +13.28% | +20.60% |
| 5-year value | ₹8,42,783 | ₹10,11,738 |
| 3-year XIRR | +8.08% | +19.58% |
| 1-year XIRR | +10.16% | +34.31% |
Holdings overlap i
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Nippon India ETF Nifty Next 50 Junior BeES | — | 9% |
| Nippon India Nifty Pharma ETF | 9% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF |
|---|---|---|
| Divi's Laboratories Limited | 5.24% | 12.28% |
| Torrent Pharmaceuticals Limited | 2.86% | 6.71% |
| Zydus Lifesciences Limited | 1.30% | 3.05% |
Sectors and company size
| Nippon India ETF Nifty Next 50 Junior BeES | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Large companies | 95.4% | 45.3% |
| Mid companies | 4.6% | 47.1% |
| Small companies | — | 7.6% |
| Top 10 holdings | 33.9% | 78.6% |
| Largest sector | Power 9% | Pharmaceuticals & Biotechnology 100% |